Snellgrove Darren

Snellgrove Darren is listed in filings as SVP at Halozyme Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jul 2, 2026, including 2 public disclosures. Recent filings connect the profile to Halozyme Therapeutics, Inc. (HALO). The current snapshot covers public activity from Jul 2, 2026. Reported amounts are shown as $9.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.